Download Our Oncolytic Virus Therapies Brochure See why BioAgilytix is experienced in developing bioanalytical strategies to investigate the mechanisms of oncolytic virus immunotherapies, from their antitumor properties to immune interaction effects. Download Brochure
Download Our Vaccine Brochure Explore the assays we use to support assessments of pathogen-derived vaccines, recombinant proteins and LVPs, nucleic acid- or vector-based vaccines, and emerging virus neutralization approaches. Download Brochure
Explore Our Gene & Cell Therapy Center Learn. Share. Discuss. Innovate Together. Find valuable resources from our scientists who share their expert perspectives on evolving methods and trends in cell & gene therapy bioanalysis. Visit the Center
Download Our Gene Therapy Brochure Learn how BioAgilytix applies deep expertise to develop robust and novel bioanalytical methods to understand the distribution, function, efficacy, and immunogenicity of innovative gene therapeutic candidates in line with regulatory requirements. Download Brochure
Supporting CAR-T Therapies: Innovation to Overcome Bioanalytical Challenges There are many bioanalytical challenges that accompany development of cell therapies such as CAR-T therapies – which is why we are focused on continually refining and innovating our methods to address those complexities. Learn how we leverage platforms like qPCR, flow cytometry, and ELISpot to meet the specificity, selectivity, and sensitivity requirements of each unique study. Read More
Download Our Cell Therapy Brochure Learn how BioAgilytix performs bioanalytical assessments to support cell therapy programs involving TIL, TCR, CAR, and other innovative modalities across a variety of delivery mechanisms and matrices. Download Brochure
Are you interested in learning more about our European laboratory located in Hamburg, Germany?Click Here close
Choose your region to learn more about our premier largemolecule global services and the BioAgilytix location closest to you.
Discussing the Modern Challenges of Single and Multiplex Biomarker Validation Biomarker validation can be confusing. Learn more about how BioAgilytix and the industry are progressing to come to some level of consensus as an industry on guidance and best practices in a blog post from Bioagilytix CSO, Dr. Afshin Safavi. Read More
Platforms
Services